相关实验视频

Updated: Jun 16, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

儿科多发性硬化症:对当前和新兴疗法有效性的系统性探索

Padideh Panahi¹, Seyedeh Tarlan Mirzohreh¹, Hooman Zafardoust¹

¹Faculty of Medicine of Tabriz University of Medical Sciences, Tabriz, Iran.

Pediatric neurology

|May 17, 2025

概括

像纳塔利祖马布和奥克雷祖马布这样的高效疗法 (HET) 显著降低了儿科多发性硬化症 (POMS) 的复发率. 这些先进的治疗方法在治疗这种罕见的神经疾病时,与中度有效疗法 (METs) 相比,具有明显的优势.

科学领域:

神经学神经学
免疫学免疫学免疫学
儿科儿科儿科

背景情况:

儿科发病多发性硬化症 (POMS) 是一种罕见的,严重的神经疾病,具有独特的诊断和治疗挑战.
新兴的治疗方案需要对其在儿科患者群体中的有效性和安全性进行系统评估.

研究的目的:

系统地审查和元分析儿童多发性硬化症 (POMS) 当前和新兴疗法的疗效.
在POMS.中提供治疗有效性和安全性概况的全面概述.

主要方法:

系统审查遵循PRISMA指导方针,搜索PubMed,Scopus,科学网络和Cochrane.
使用ROBINS-I和ROBINS-II评估偏差风险;用GRADE评估证据确定性.
使用综合元分析软件进行的元分析,使用子组和灵敏度分析来解决异质性.

主要成果:

包括65项研究;52项在元分析中. 证据的确定性一般是中等的 (GRADE).
高效疗法 (HETs),包括natalizumab和ocrelizumab,与中等效疗法 (METs) (效果大小: -2.028).相比,高效疗法 (HETs),包括natalizumab和ocrelizumab,在年度复发率 (ARR) (效果大小: -2.821) 中显示出更大的降低.
HETs,尤其是natalizumab和rituximab,显著降低了扩展残疾状态量表 (EDSS). 与MET相关的ARR降低与治疗持续时间相关.

结论:

像纳塔利祖马布和奥克雷祖马布这样的高效疗法 (HET) 在治疗儿科多发性硬化症 (POMS) 中表现出显著的有效性.
在降低复发率方面,HET比MET更有效,为POMS患者提供了明显的治疗优势.

关键词:

障碍障碍是指残疾人的残疾.医学医学医学医学医学这就是POMS的意义.儿科发病的多发性硬化症复发复发的情况治疗疗法治疗疗法

更多相关视频

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

相关概念视频

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...